Xconomy National

Archives

by in

Entry	Author	Date	Location
Aastrom Enters Final-Stage Trial With Stem-Cell Therapy for CLI Patients	Sarah Schmid	08/09/11	Detroit
NeoStem Acquires Amorcyte	João-Pierre S. Ruth	07/15/11	New York
Pathway Medical Grinds It Out, Seeks Profit Formula, Three Years After FDA Approval	Luke Timmerman	06/08/11	Seattle
CardioDx Raises $40M	Wade Roush	03/07/11	San Francisco
Pfizer Adding 350 Jobs in MA, Globe Reports	Ryan McBride	02/02/11	Boston
Genzyme to Let Diagnostics Unit Loose for $265M	Ryan McBride	11/18/10	Boston
Arena Reloads for Round 2 with FDA, With More Data on Weight Loss Drug in Diabetes Patients	Luke Timmerman	11/09/10	San Diego
Biogen Idec Chief Aims to Make Firm More Like Biotech and Less Like Pharma with Restructuring Plan	Ryan McBride	11/04/10	Boston
Biogen Idec Offering Jobs to Quarter of San Diego Workers, While Most Get Layoff Notices	Ryan McBride	11/03/10	Boston
Arch, Hutch Stand to Gain From “Hibernation on Demand” Through Ikaria IPO	Luke Timmerman	11/02/10	Seattle
Cerenis Adds $13.9M to C Round	Ryan McBride	10/21/10	Detroit
Aastrom Gets FDA Fast Track Status, Gears Up for Pivotal Study of Cell Therapy	Luke Timmerman	10/18/10	Detroit
Synthetech Acquired for $19.2M	Thea Chard	09/14/10	Seattle
SonoSite’s New Frontier: High-Res Ultrasound to See a Mouse Heartbeat, the Inside of Your Blood Vessels, & More	Luke Timmerman	06/01/10	Seattle
LightLab, Medical Imager with MIT Roots, Bought by St. Jude for $90M	Ryan McBride	05/20/10	Boston
Technology Alliance Showcases Five Companies in Sensors, Mobile Displays, and Drug Therapies: Investors Take Notice	Gregory T. Huang	04/22/10	Seattle
$5.3M for Corindus	Ryan McBride	11/19/09	Boston
Excaliard, an Isis Spinoff With Anti-Scarring Drug, Marches Ahead in Clinical Trials	Luke Timmerman	10/29/09	San Diego
Pathway Medical Learns Lessons During Tougher Than Expected First Year on Market	Luke Timmerman	10/20/09	Seattle
San Diego’s Accumetrics Raises $16.5M in Fifth Round of Venture Funding	Bruce V. Bigelow	10/06/09	San Diego
Minnow Medical Aims to Commercialize Improved Device for Treating Peripheral Artery Disease	Bruce V. Bigelow	09/09/09	San Diego
San Diego Biotech Startups Raise New Cash to Treat Anemia, Heart Disease and More	Bruce V. Bigelow	08/19/09	San Diego
Amira Pharmaceuticals Can Breathe Easier After Mouse Study	Denise Gellene	06/30/09	San Diego
Genzyme Offers Glimpse at Growth Engine, New Drugs for High Cholesterol, Gaucher’s	Luke Timmerman	05/07/09	Boston
TargAnox Launches with $5.1M Series A Round, Targeting Oxidative Stress to Treat Diseases	Ryan McBride	03/30/09	Boston
Dicerna Aims to Gain Foothold in RNAi World With More Potent, Longer-Lasting Gene Silencers	Luke Timmerman	01/30/09	Boston
Page 1 of 1